Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoyun Kao

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Archives of Biochemistry and Biophysics|December 7, 2023
Rational design of humanized antibody inhibitors for cathepsin SPo-Wen Yu, Guoyun Kao, Zhefu Dai, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
PAR-Driven Condensation Maintains Stalled Replication Fork StabilityLei Zhang, Zeyu Zhang, Timothy R O'Leary, et al.
Frontiers in Immunology|December 1, 2022
pyTCR: A comprehensive and scalable solution for TCR-Seq data analysis to facilitate reproducibility and rigor of immunogenomics researchKerui Peng, Jaden Moore, Mohammad Vahed, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 21, 2025
Synthesis of Bispecific Conjugates by ADP-Ribosyl CyclasesSunny H Kim, Arshad J Ansari, Lei Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 20, 2025
Preclinical assessment of genetically modified exosomes for colorectal cancer immunotherapyThuc Oanh Hoang, Lei Zhang, Sunny H Kim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2025
Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemiaLei Zhang, Guoyun Kao, Yuanteng Zhao, et al.
JACS Au|November 29, 2024
Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell LabelingGuoyun Kao, Xiao-Nan Zhang, Fariborz Nasertorabi, et al.
Nature Communications|December 19, 2025
A versatile platform for chemical engineering of exosomes empowered by ADP-ribosyl cyclasesLei Zhang, Srinivasarao Singireddi, Arshad J Ansari, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 18, 2025
Targeting prostate cancer with site-specific antibody-drug conjugates enabled by tandemly fused ADP-ribosyl cyclasesLei Zhang, Mashael F Aldossari, Arshad J Ansari, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Archives of Biochemistry and Biophysics|December 7, 2023
Rational design of humanized antibody inhibitors for cathepsin SPo-Wen Yu, Guoyun Kao, Zhefu Dai, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
PAR-Driven Condensation Maintains Stalled Replication Fork StabilityLei Zhang, Zeyu Zhang, Timothy R O'Leary, et al.
Frontiers in Immunology|December 1, 2022
pyTCR: A comprehensive and scalable solution for TCR-Seq data analysis to facilitate reproducibility and rigor of immunogenomics researchKerui Peng, Jaden Moore, Mohammad Vahed, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 21, 2025
Synthesis of Bispecific Conjugates by ADP-Ribosyl CyclasesSunny H Kim, Arshad J Ansari, Lei Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 20, 2025
Preclinical assessment of genetically modified exosomes for colorectal cancer immunotherapyThuc Oanh Hoang, Lei Zhang, Sunny H Kim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2025
Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemiaLei Zhang, Guoyun Kao, Yuanteng Zhao, et al.
JACS Au|November 29, 2024
Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell LabelingGuoyun Kao, Xiao-Nan Zhang, Fariborz Nasertorabi, et al.
Nature Communications|December 19, 2025
A versatile platform for chemical engineering of exosomes empowered by ADP-ribosyl cyclasesLei Zhang, Srinivasarao Singireddi, Arshad J Ansari, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 18, 2025
Targeting prostate cancer with site-specific antibody-drug conjugates enabled by tandemly fused ADP-ribosyl cyclasesLei Zhang, Mashael F Aldossari, Arshad J Ansari, et al.
Pageof 1